Find the latest pharmaceutical market place for formulations enquiry about Doripenem on PharmaCompass.com.

india-flag Flag

Various Finished Dosage Formulations needed in India [ENA20978]

A company that focuses on distribution of various finished formulations is looking for suppliers of various finished dosage formulations. The suppliers must support this enquiry with ACTD dossier and GMP.
1. Ertapenem (500 mg) Vials. The required quantity is 60,000 units in the first year, 85,000 units in the second year, and 95,000 units in the third year.
2. Ertapenem (1000 mg) Vials. The required quantity is 100,000 units in the first year, 120,000 units in the second year, and 135,000 units in the third year.
3. Doripenem (500 mg) Vial. The required quantity is 85,000 units in the first year, 90,000 units in the second year, and 100,000 units in the third year.
4. Ceftazidime Avibactam (2500 mg) Vial. The required quantity is 50,000 units in the first year, 65,000 units in the second year, and 85,000 units in the third year.
5. Aztreonam (1 g) Injection. The required quantity is 130,000 units in the first year, 160,000 units in the second year, and 240,000 units in the third year.
6. Aztreonam (2 g) Injection. The required quantity is 100,000 units in the first year, 125,000 units in the second year, and 145,000 units in the third year.
7. Ampicillin and sulbactam (1.5 g) Injection. The required quantity is 500,000 units/ annum.
8. Ampicillin and sulbactam (750 g) Injection. The required quantity is 400,000 units/ annum.
9. Piperacillin and Tazobactam (2.25 g) Injection. The required quantity is 300,000 units/ annum.
10. Piperacillin and Tazobactam (4.5 g) Injection. The required quantity is 250,000 units.

Reply

28 Oct 2024

Various Finished Dosage Formulations needed in Vietnam [ENA13102]

A large pharmaceutical company based in India that deals in various segments such as gynaecology, cardiovascular, diabetology, asthma, paediatric, CNS, GI and NSAIDs is looking for suppliers of Various Finished Dosage Formulations for commercial purpose.
1. Rivaroxaban (10 mg, 15 mg & 20 mg) Tablets
2. Erythropoietin (2000 IU) Injections
3. Doripenem (250 mg & 500 mg) Injections

Reply

25 Mar 2022

Methylprednisolone and Dexamethasone injections needed in Vietnam [ENA03465]

A company providing global sourcing, technology transfer and pegylation services to pharmaceutical, biotech and medical devices companies is searching for below formulations:
1. Methylprednisolone 40mg injection | Qty 1st year: 180,000 | Qty 2nd year: 280,000 | Qty 3rd year: 400,000
2. Dexametasone inj 0.5mg injections | Qty 1st year: 400,000 | Qty 1st year: 400,000 | Qty 1st year: 400,000
3. Dexametasone inj 2mg injections | Qty 1st year: 400,000 || Qty 1st year: 400,000 | | Qty 1st year: 400,000
4. Doripenem 500mg - DORIBAX® / JANSSEN-CILAG | Qty 1st year: 30,000 | Qty 1st year: 40,000 | Qty 1st year: 50,000
5. Ertapenem 1g - INVANZ® / Merck Sharp & Dohme Corp | Qty 1st year: 100,000 | Qty 1st year: 120,000 | Qty 1st year: 150,000

Reply

18 Feb 2019

Enquiry//Cephalosporin and Penem Technology Transfer needed for a new facility coming up in Qatar [ENA00106]

The first phase of a pharmaceutical project, currently underway in Qatar, will involve the manufacture of Cephalosporin and Penem formulations. Dr. Majid Feddah, the chief consultant on the project will be visiting CPhI Barcelona and is interested in meeting partners who would be open to technology transfer agreements. Interested partners can learn more about the project by viewing its PharmaCompass profile page at the following link - https://www.pharmacompass.com/api-manufacturers/qatar-pharmaceutical-industries

Reply

28 Sep 2016